Edesa Biotech, Inc.
Edesa Biotech develops monoclonal antibodies and small molecules for inflammatory and immune diseases.
SCHEDULE 13GAug 26Latest SEC filing
Aug 20Latest story
Sign inSign inEdesa Biotech develops monoclonal antibodies and small molecules for inflammatory and immune diseases.